Histofy
histofy.ai
Biotechnology
Drug Discovery
Artificial Intelligence
Claim pageClaim
Follow
Overview
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Latest round
Venture round
Oct 2025 · 11 mo ago
Team
11-50
employees, estimated range
Grants
$444k
1 grant · CORDIS
The money's age
Fresh money
11 months since the last round · not hiring
Momentum
20/100
fresh money
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 21, 2025
Raised a round Venture round
May 1, 2025
Raised a round Venture round
May 3, 2023
Raised a round Venture round
Dec 22, 2022
Raised a round Venture round
Nov 1, 2022
Won a grant $444k · CORDIS
Nov 9, 2021
Founded per the company register
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Venture round | Oct 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | May 2025 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | May 2023 | — | — | find-and-update.company-information.service.gov.uk |
| Venture round | Dec 2022 | — | — | find-and-update.company-information.service.gov.uk |
| Grant | Nov 2022 | $444k | — | CORDIS |
Registers and programsofficial lists and records that name the company
| Legal entity | HISTOFY LTD | Companies House |
| Registered | 9 Nov 2021 |
Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Our goal is to streamline drug development in order to accelerate patient access to important medical therapies.
Solutions for drug discovery and diagnostics. SPR analysis, antibody selection and LFA services. K-One sensor chips & bioconjugates supply.
Company Home > Company Kill The Illness, Not The Patient At Prosemble, our vision is to improve treatments using nanotechnology…
Ngmbio develops life-changing medicines rooted in powerful biology, including NGM120 for hyperemesis gravidarum and cancer cachexia.
AnaBios provides high quality human tissue and cells, including heart, lung and dorsal root ganglia, for drug discovery & academic research.
Kriya is building durable medicines designed to replace chronic re-treatment with a single administration—therapeutic medicines that can…
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Coventry
United Kingdom
HQ
Get in touch
10-50 est. staff
Unit 33, The Venture Centre, University of Warwick Science Park, Sir William Lyons Road, Coventry, CV4 7EZ, United Kingdom
Financials
Total raised
$444k
Latest round
Venture - Series Unknown
Funding rounds
5